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Purpose: To evaluate the efficacy of arteriovenous (AV) sheathotomy with internal limiting membrane peeling 
for persistent or recurrent macular edema after intravitreal triamcinolone injection and/or laser photocoagu-
lation in branch retinal vein occlusion.
Methods: Twenty-two eyes with branch retinal vein occlusion (BRVO) with recurrent macular edema under-
went vitrectomy with AV sheathotomy and internal limiting membrane peeling. All eyes had previous 
intravitreal triamcinolone injection and/or laser photocoagulation for macular edema. The best corrected visual 
acuity (BCVA), fluorescein angiography and optical coherence tomography (OCT) before and after surgery 
were compared. 
Results: The mean preoperative BCVA (log MAR) were 0.79 ±0.29 and postoperative BCVA (log MAR) at 
3 months was 0.57±0.33. And improvement of visual acuity ≥2 lines was observed in 10 eyes (45%). The 
mean preoperative fovea thickness measured by OCT was 595.22±76.83 μ m (510-737 μ m) and postoperative 
fovea thickness was 217.60±47.33 μ m (164-285 μ m). 
Conclusions: Vitrectomy with AV sheathotomy can be one treatment option for the patients with recurrent 
macular edema in BRVO.  Korean Journal of Ophthalmology 20(4):210-214, 2006
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Branch retinal vein occlusion is the second most common 
cause of retinal vascular disease after diabetic retinopathy.
1,2 
Many patients with BRVO experience a decrease in visual 
acuity because of macular edema, retinal ischemia or hemor-
rhage.
2 The Branch Retinal Vein Occlusion Study demon-
strated that eyes treated with argon laser photocoagulation for 
macular edema gained a mean improvement of visual acuity 
of 1.3 lines whereas the control group gained 0.2 lines.
2 
Recently, improvement in macular edema and visual acuity 
after intravitreal triamcinolone injections on macular edema 
in BRVO have been reported.
3 However, these therapeutic 
results were not satisfactory in many cases because recurrent 
or persistent macular edema is common even after laser 
photocoagulation or intravitreal triamcinolone injections.
4 
After the first report by Osterloh and Chales in 1988, 
several investigators reported significant improvement of 
macular edema and visual acuity after arteriovenous sheatho-
tomy for decompression of macular edema in BRVO.
5-9 This 
surgical approach is based on the fact that BRVO takes place 
at the site of arteriovenous crossing where the artery and the 
vein shared a common vascular adventitia. Although the 
exact mechanism responsible for the improvement of visual 
acuity after vitrectomy and arteriovenous sheathotomy is still 
not clear, Mason et al reported that surgery halved the visual 
angle in 75 % of patients compared with 40% of the control 
group.
10 Charbonnel et al also reported visual acuity improve-
ment of two ETDRS lines or more in 69% of patients with 
a mean gain of 1.9 ETDRS lines.
11 However, most of these 
results are in eyes with relatively short BRVO duration and 
excluded the eyes with recurrent or persistent macular edema 
in BRVO after laser or intravitreal triamcinolone injections.
The purpose of this study is to investigate the anatomic 
and functional results after arteriovenous sheathotomy with 
ILM peeling for persistent or recurrent macular edema in 
BRVO.
Materials and Methods
A retrospective, nonrandomized study was conducted in 22 
eyes (22 patients) with BRVO and recurrent or persistent 
macular edema after laser or intravitreal triamcinolone injec-JH  Sohn,  et  al.  A-V  SHEATHOTOMY  FOR  BRVO
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p  value
§
Age  (years)
Gender  (men/women)
Occluded  vein  (ST
†/IT
‡)
Artery  over  vein  at  pathologic  crossing
Preop  BCVA*  (log  MAR)
Preop  foveal  thickness  (μ m)
Estimated  duration  of  symptoms  (months)
55±23.33
5/1 7
17 / 4
9/2 2
0.79±0.29  (0.3-1.2)
595.22±76.83  μ m  (510-737)
8.95±12.28
0.681
0.737
0.737
0.691
0.692
*BCVA:  Best  corrected  visual  acuity, 
†ST:  Superotemporal, 
‡IT:  Inferotemporal, 
§p  value:  Partial  correlation.
Table 1. Summary  of  Preoperative  Clinical  Characteristics 
tions. Inclusion criteria were BCVA of 0.3 or worse in log 
MAR unit as result of recurrent or persistent macular edema 
or hemorrhages secondary to BRVO in spite of laser photo-
coagulation or intravitreal triamcinolone injections. Exclusion 
criteria were the presence of other retinal vascular diseases, 
marked macular ischemia, vitreous hemorrhage or retinal 
neovascularization secondary to BRVO. The duration of 
symptoms was not used for the exclusion criteria. All patients 
provided written informed consent. The BCVA in logMAR 
units using the Snellen chart, indirect ophthalmoscopic and 
slit-lamp examination, fundus photography, fluorescein 
angiography, and central fovea thickness by OCT (Humphrey 
model 3000; Humphrey Instruments, San Leandro, CA) was 
checked preoperatively and postoperative mean 3 months. 
The improvement of visual acuity was defined as 2 lines or 
more of improvement of BCVA (Snellen visual acuity).
All surgeries were performed by one author (S.J.). Stan-
dard pars plana vitrectomy was performed and followed by 
removal of posterior hyaloid membrane. The involved AV 
crossing site was identified and the common AV crossing 
sheath was incised by a BRVO knife (Synergetics, USA). 
The completion of AV dissection was confirmed by the 
elevation of the overlying vessels. But, in cases having very 
slender and sclerotic thread like overlying vessels, complete 
A-V separation was not performed obsessively not to cut the 
vessel. The internal limiting membrane (ILM) in the macular 
area was removed using ILM forceps (Eckardt end-gripping 
foceps, D.O.R.C) without triamcinolone or indocyanine green 
dye staining. Laser photocoagulation was done on the 
ischemic retina in cases of large ischemic area. Simultaneous 
phacoemulsification and aspiration of cataracts with intra-
ocular lens implantation was performed in 10 eyes (45%).
The preoperative BCVA, preoperative central foveal 
thickness, duration of symptoms, patient’s age and sex, 
associated systemic illness such as hypertension were 
evaluated. 
Results
Baseline demographics of the recruited patients are given 
in Table 1. There was no significant intraoperative or post-
operative retinal bleeding, retinal tear, or detachments.
The mean preoperative BCVA (log MAR) was 0.79±0.29 
Fig. 1. The relationship between the preoperative visual acuity and 
postoperative  visual  acuity.  The  improvement  of  visual  acuity  is 
statistically  significant  (p<0.01,  Chi  squared  test). 
Preva:  preoperative  visual  acuity  (log  MAR),  Postva:  post-
operative  visual  acuity  (log  MAR)
(0.3-1.2) and postoperative BCVA (log MAR) was 0.57±
0.33 (0.05-1.2). Postoperative BCVA was significantly better 
than preoperative BCVA (p<0.01, Fig. 1). The mean duration 
of symptoms before treatment (laser or IVTA) was 8.95±
12.28 months. The interval between the recurrence of macular 
edema after IVTA or laser treatment and surgery was 3.05±
2.08 months. All eyes did not have PVD before the surgery.
Ten eyes (45%) had more than 2 lines of improvement of 
visual acuity and 4 eyes (18%) had more than 4 lines of 
visual improvement. Visual acuity remained stable during 
13.53±4.18 months (9-22 months) of follow up period there-
after. Two eyes (9%) had decreased visual acuity because of 
persistent macular edema. The mean preoperative central 
fovea thickness measured by OCT was 595.22±76.83 μ m 
(510-737 μ m) and postoperative fovea thickness was 217.60
±47.33  μ m (164-285 μ m). At obstruction site, the vein 
crossed over the artery in 12 eyes (54%). In twenty (91%) 
eyes, the tertiary branch retinal vein was responsible for the 
pathologic crossing. Restoration of blood flow, intraoperative 
reestablishment of a red column of erythrocytes through the 
previously closed vessel, was identified in all cases having Korean  J  Ophthalmol  Vol.20,  No.4,  2006
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Fig. 3. Preoperative  and  postoperative  fundus  photography  and  fluorescein  angiography  of  a  67  year-  old  patient  with 
inferotemporal  BRVO  (visual  acuity  0.2).  (A)  Preoperative  fluorescein  angiography  showing  retina  ischemia  in  infero-
temporal  area  including  macula  3  months  after  IVTA.  (B)  Postoperative  fluorescein  angiography  at  1  year  after  surgery 
(visual  acuity  0.4)  with  a  lack  of  blocked  fluorescence  and  minimal  leakage.  (C)  Preoperative  OCT  with  central  fovea 
thickness  637  μ m.  (D)  Postoperative  OCT  15  months  after  surgery  with  fovea  thickness  183  μ m.
Fig. 2. Preoperative and postoperative fundus photography and OCT in a 64 year-old patient with BRVO. (visual acuity 
0.1) (A) Widespread retina hemorrhage and exudation. (B) Preoperative fluorescein angiography of nonperfusion area after 
3  m o n t h s  a f t e r  l a s e r  a n d  I V T A  t r eatment.  (C)  Color  fundus  photography  1  year  after  surgery.  (visual  acuity  0.3).  (D) 
Preoperative  OCT  showed  cystoid  macular  edema  with  central  foveal  thickness  552  μ m.  E.  Postoperative  OCT  with 
decreased  macular  edema  with  central  foveal  thickness  214  μ m.
overlying arteries at obstruction site, but not in cases having 
sclerotic thread-like overlying veins. Three eyes (14%) had 
phacoemulsification and aspiration of cataracts with intra-
ocular lens implantation during follow up period. Cataract 
surgery did not influence the postoperative improvement of 
visual acuity (partial correlation, p=0.627). None of the 
expected factors such as preoperative BCVA, preoperative 
foveal thickness, duration of symptoms, patient’s age and sex 
had a significant effect on postoperative visual improvement 
(Table 1).
Discussion
Branch retinal vein occlusion is a common retinal vascular 
disorder. The interruption of venous flow in these eyes 
almost always occurs at a retinal arteriovenous intersection, 
where a retinal artery crosses a retinal vein.
12 The thickened 
artery compresses the vein, which starts the cascade of JH  Sohn,  et  al.  A-V  SHEATHOTOMY  FOR  BRVO
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turbulence of blood flow, endothelial damage, and thrombosis 
in the vein.
12 The natural history of BRVO is known to be 
favorable, and 53% of patients achieve final visual acuity 
of 20/40 or better.
13 Intraretinal hemorrhage, macular 
edema, and capillary nonperfusion may be the cause in cases 
with poor visual acuity.
13 The BRVO Study showed 
significant improvement of visual acuity 3 years after grid 
laser treatment, with an average visual acuity of 20/40 to 
20/50 in the treated group and 20/70 in the control group.
13 
But the BRVO study did not include cases of foveal 
hemorrhage or ischemia, or cases of persistent macular edema 
after grid laser photocoagulation, which are the majority of 
BRVO-associated morbidities. Various medical and surgical 
treatments have been tried to treat complications of BRVO. 
Ozkiris and Evereklioglu reported that intravitreal injection of 
corticosteroid for macular edema in BRVO resulted in 
significant improvement in visual acuity, from baseline of 
0.98±0.19 to a maximum of 0.24±0.24 logMAR during a 
mean follow-up period of 6.3 months.
14,15 However, the 
monotherapy of corticosteroid intravitreal injection cannot 
prevent recurrent macular edema.
4 Pars plana vitrectomy 
with removal of posterior cortical vitreous can improve 
oxygen supply to the ischemic inner retina by enhancing fluid 
currents in the vitreous cavity. The resolution of retinal 
hypoxia might suppress retinal neovascularization and thus 
reduce macular edema.
16 
Since the first report by Osterloh and Chales, many 
authors have reported the improvement of macular edema and 
visual acuity by vitrectomy with AV sheathotomy in BRVO.
17 
Charbonnel et al
11 reported that improvement of visual acuity 
was more frequent in eyes with removal of ILM and without 
PVD. The exact role of AV sheathtotomy and timing of 
surgery in BRVO are still controversial. Yamamoto et al
18 
reported AV sheathotomy and PVD significantly reduced 
macular edema, but there was no significant difference in 
macular function following either procedure. However, 
Lakhanpal et al
19 reported that AV sheathotomy without 
vitrectomy can improve macular edema and hemorrhage and 
also improve visual acuity. Many authors advocate that early 
surgery may be associated with better anatomical and 
functional outcomes.
10,20 Although we expected a lower rate 
of improvement of macular edema and visual acuity in this 
study, because of the chronic nature of the study candidates 
and possibility of long standing subretinal fluid causing RPE 
damages, there was improvement of visual acuity in 16 eyes 
in 22 eyes (75%), which was similar results with previous 
results.
10,11 This result may be in part coincidence with the 
vitrectomy and surgical PVD may playing a more important 
role than AV sheathotomy, and postoperative visual acuity 
improvement may be due to the reduction of macular edema 
and not to a better blood flow in occluded territory itself. But 
the effect of AV sheathotomy cannot be ruled out because 
we did not compare eyes with and without AV sheathtotomy 
and did not consider an additional effect of ILM removal on 
macular edema resolution.
21 Another interesting finding in 
our study was at pathologic AV crossing site, vein crossed 
anterior to the artery in 12 eyes (54.5%). This finding is 
opposite to previous reports that most of pathologic AV 
crossing in BRVO occurs where the artery is anterior to the 
vein.
14,21 Considering that our study patients had persistent or 
recurrent macular edema and hemorrhage despite the treat-
ment, vein-overcrossing BRVO may be more associated with 
poor response to laser or corticosteroid intravitreal injection 
more than artery over-crossing BRVO. In these cases, dual 
compression outside from the underlying artery and inside 
from intraocular pressure might cause more severe and 
refractory venous obstructions. But this finding needs more 
evaluation in a larger clinical observation. No complications 
have been observed in our study except for cataract 
progression in 3 eyes (14%). This study has several limita-
tions. Patients were not randomly assigned to the treatments 
group, there was no control group, and the possible additional 
effect of the ILM removal on macular edema resolution was 
not investigated. 
In conclusion, this study showed a favorable effect of 
vitrectomy and AV sheathotomy in eyes with persistent or 
recurrent macular edema after laser photocoagulation and/or 
corticosteroid intravitreal injection and vitrectomy with AV 
sheathotomy can be one treatment option for the patients with 
recurrent macular edema in BRVO.
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